Jongen, J.; Schneider, J.; Kahlke, V.; Laubert, T.
Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218. J. Clin. Med. 2022, 11, 2495.
https://doi.org/10.3390/jcm11092495
AMA Style
Jongen J, Schneider J, Kahlke V, Laubert T.
Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218. Journal of Clinical Medicine. 2022; 11(9):2495.
https://doi.org/10.3390/jcm11092495
Chicago/Turabian Style
Jongen, Johannes, Jessica Schneider, Volker Kahlke, and Tilman Laubert.
2022. "Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218" Journal of Clinical Medicine 11, no. 9: 2495.
https://doi.org/10.3390/jcm11092495
APA Style
Jongen, J., Schneider, J., Kahlke, V., & Laubert, T.
(2022). Comment on Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes. J. Clin. Med. 2022, 11, 218. Journal of Clinical Medicine, 11(9), 2495.
https://doi.org/10.3390/jcm11092495
